Article Information
History
- February 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Marielle Bedotto1,
- Pierre-Edouard Fournier1,2,
- Linda Houhamdi1,2,
- Philippe Colson1,2 and
- Didier Raoult1,2,*
- 1IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France
- 2Aix-Marseille Univ., Institut de Recherche pour le Développement (IRD), Assistance Publique - Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France
- ↵*Corresponding author: Didier RAOULT, IHU - Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France. Tel.: +33 413 732 401, Fax: +33 413 732 402; email: didier.raoult{at}gmail.com
Posted February 11, 2021.
Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants
